You just read:

Oncolytics Biotech® Inc. Reports Preliminary Data from Randomized Phase II Study of REOLYSIN® in Non-Small Cell Lung Cancer

News provided by

Oncolytics Biotech Inc.

May 19, 2016, 06:00 ET